Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bacille calmette-guerin (8 trials)
aeras-402 (7 trials)
aeras-404 (6 trials)
aeras-456 (2 trials)
candida albicans allergen (1 trial)
gsk692342 (4 trials)
h56 (3 trials)
ic31 (4 trials)
live oral poliovirus type 1, 2 and 3 (1 trial)
menjugate (1 trial)
mtbvac (1 trial)
mva85a (3 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
tritanrix-hepb (1 trial)
aeras-422 (1 trial)
bcg tice (2 trials)
dar-901 (1 trial)
gla-se (2 trials)
h4 (1 trial)
id93 (2 trials)
sodium chloride (1 trial)
Infections (Phase 2)
Latent Tuberculosis (Phase 2)
Recurrence (Phase 2)
Tuberculosis (Phase 4)
Tuberculosis, Pulmonary (Phase 2)
Trials (34 total)
Trial APIs (21 total)